These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 9665473
1. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat. Ho SM, Leav I, Ghatak S, Merk F, Jagannathan VS, Mallery K. Am J Pathol; 1998 Jul; 153(1):131-9. PubMed ID: 9665473 [Abstract] [Full Text] [Related]
2. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats. Yu M, Leav BA, Leav I, Merk FB, Wolfe HJ, Ho SM. Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674 [Abstract] [Full Text] [Related]
3. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate. Ghatak S, Oliveria P, Kaplan P, Ho SM. Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805 [Abstract] [Full Text] [Related]
4. TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin. Russo P, Warner JA, Huryk R, Perez G, Heston WD. Prostate; 1994 May; 24(5):237-43. PubMed ID: 8170836 [Abstract] [Full Text] [Related]
5. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats. Ho SM, Yu M. J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144 [Abstract] [Full Text] [Related]
6. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta. Ho SM, Leav I, Merk FB, Yu M, Kwan PW, Ziar J. Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268 [Abstract] [Full Text] [Related]
7. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate. Kaplan PJ, Leav I, Greenwood J, Kwan PW, Ho SM. Carcinogenesis; 1996 Dec; 17(12):2571-9. PubMed ID: 9006091 [Abstract] [Full Text] [Related]
8. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Miyake H, Nelson C, Rennie PS, Gleave ME. Cancer Res; 2000 Jan 01; 60(1):170-6. PubMed ID: 10646870 [Abstract] [Full Text] [Related]
9. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats. Ho SM, Yu M. Cancer Res; 1993 Feb 01; 53(3):528-32. PubMed ID: 7678774 [Abstract] [Full Text] [Related]
10. Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Lau KM, Leav I, Ho SM. Endocrinology; 1998 Jan 01; 139(1):424-7. PubMed ID: 9421443 [Abstract] [Full Text] [Related]
11. Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment. Astancolle S, Guidetti G, Pinna C, Corti A, Bettuzzi S. J Endocrinol; 2000 Nov 01; 167(2):197-204. PubMed ID: 11054633 [Abstract] [Full Text] [Related]
12. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC. Carcinogenesis; 2001 Jun 01; 22(6):965-73. PubMed ID: 11375906 [Abstract] [Full Text] [Related]
13. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Lane KE, Leav I, Ziar J, Bridges RS, Rand WM, Ho SM. Carcinogenesis; 1997 Aug 01; 18(8):1505-10. PubMed ID: 9276623 [Abstract] [Full Text] [Related]
14. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Miyake H, Nelson C, Rennie PS, Gleave ME. Cancer Res; 2000 May 01; 60(9):2547-54. PubMed ID: 10811138 [Abstract] [Full Text] [Related]
15. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. Brändström A, Westin P, Bergh A, Cajander S, Damber JE. Cancer Res; 1994 Jul 01; 54(13):3594-601. PubMed ID: 8012987 [Abstract] [Full Text] [Related]
16. Expression of TRPM-2 during involution and regeneration of the rat liver. Helvering LM, Richardson KK, Horn DM, Wightman KA, Hall RL, Smith WC, Engelhardt JA, Richardson FC. Cancer Lett; 1993 Jul 30; 71(1-3):133-42. PubMed ID: 7689926 [Abstract] [Full Text] [Related]
17. Expression of a 74-kDa nuclear factor 1 (NF1) protein is induced in mouse mammary gland involution. Involution-enhanced occupation of a twin NF1 binding element in the testosterone-repressed prostate message-2/clusterin promoter. Furlong EE, Keon NK, Thornton FD, Rein T, Martin F. J Biol Chem; 1996 Nov 22; 271(47):29688-97. PubMed ID: 8939902 [Abstract] [Full Text] [Related]
18. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Rittmaster RS, Magor KE, Manning AP, Norman RW, Lazier CB. Mol Endocrinol; 1991 Jul 22; 5(7):1023-9. PubMed ID: 1719382 [Abstract] [Full Text] [Related]
19. Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate. Desai KV, Michalowska AM, Kondaiah P, Ward JM, Shih JH, Green JE. Mol Endocrinol; 2004 Dec 22; 18(12):2895-907. PubMed ID: 15358834 [Abstract] [Full Text] [Related]
20. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. Leav I, Galluzzi CM, Ziar J, Stork PJ, Ho SM, Loda M. Lab Invest; 1996 Sep 22; 75(3):361-70. PubMed ID: 8804359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]